首页> 外文OA文献 >Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat

【2h】

Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat

机译：组蛋白脱乙酰酶抑制剂在复发难治性多发性骨髓瘤中的作用：对vorinostat和panobinostat的关注

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Salma Afifi; Angela Michael; Mahshid Azimi; Mabel Rodriguez; Nikoletta Lendvai; Ola Landgren;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor [J] . Kimberly A Redic, Shannon M Hough, Erika M Price OncoTargets and therapy . 2016,第4期

机译：复发性或复发性和难治性多发性骨髓瘤的治疗方法的临床进展：首个组蛋白脱乙酰酶抑制剂panobinostat的影响
2. Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma [J] . Expert review of anticancer therapy . 2015,第7期

机译：Panobinostat：一种新型泛脱乙酰酶抑制剂，用于治疗复发或难治性多发性骨髓瘤
3. Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma (vol 15, pg 737, 2015) [J] . Richardson P. G., Laubach J. P., Lonial S. Expert review of anticancer therapy . 2015,第9期

机译：Panobinostat：一种新型泛脱乙酰酶抑制剂，用于治疗复发或难治性多发性骨髓瘤（第15卷，第737页，2015年）
4. The Tricyclic Antidepressant Amitriptyline Inhibits D-Cyclin Transactivation and Induces Myeloma Cell Apoptosis by Inhibiting Histone Deacetylases: In Vitro and In Silico Evidence [C] . Xinliang Mao, Depei Wu, Suzanne Trudel, International conference of molecular simulations and applied informatics technologies . 2012

机译：三环抗抑郁药阿米替林通过抑制组蛋白脱乙酰基酶抑制D-cyclin反式激活并诱导骨髓瘤细胞凋亡：体外和计算机证据。
5. The Synthetic Oleanane Triterpenoids and the Histone Deacetylase Inhibitor Vorinostat Cooperate to Delay Tumor Development in a Transgenic Model of Estrogen Receptor -- Negative Breast Cancer. [D] . Tran, Kim M. 2012

机译：合成的齐墩果烷三萜类化合物和组蛋白脱乙酰基酶抑制剂伏立诺他合用以延迟雌激素受体-阴性乳腺癌转基因模型中的肿瘤发展。
6. Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat [O] . Salma Afifi, Angela Michael, Mahshid Azimi, -1

机译：组蛋白去乙酰化酶抑制剂在难治性多发性骨髓瘤复发中的作用：以伏立诺他和帕诺比司他为重点
7. Efficacy and toxicity of histone deacetylase inhibitors in relapsed/refractory multiple myeloma: Systematic review and meta‑analysis of clinical trials [O] . Xiao Gao, Lijing Shen, Xiang Li, 2019

机译：复发/难治多骨髓瘤中组蛋白脱乙酰酶抑制剂的疗效和毒性：系统评论和临床试验的荟萃分析
8. Combinations of Novel Histone Deacetylase and Bcr-Abl Inhibitors in the Therapy of Imatinib Mesylate-Sensitive and -Refractory Bcr-Abl Expressing Leukemia [R] . Bhalla, K. 2008

机译：新型组蛋白去乙酰化酶和Bcr-abl抑制剂联合治疗伊马替尼甲磺酸盐敏感和难治性Bcr-abl表达白血病

Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat

著录项

引文网络

相似文献

相关主题

期刊订阅